DK1093380T3 - Komponent B som angiogent middel i kombination med humane vækstfaktorer - Google Patents

Komponent B som angiogent middel i kombination med humane vækstfaktorer

Info

Publication number
DK1093380T3
DK1093380T3 DK99934563T DK99934563T DK1093380T3 DK 1093380 T3 DK1093380 T3 DK 1093380T3 DK 99934563 T DK99934563 T DK 99934563T DK 99934563 T DK99934563 T DK 99934563T DK 1093380 T3 DK1093380 T3 DK 1093380T3
Authority
DK
Denmark
Prior art keywords
combination
human growth
component
growth factors
angiogenic agent
Prior art date
Application number
DK99934563T
Other languages
English (en)
Inventor
Marina Ziche
Silvia Donini
Francesco Borrelli
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1093380T3 publication Critical patent/DK1093380T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK99934563T 1998-07-09 1999-07-02 Komponent B som angiogent middel i kombination med humane vækstfaktorer DK1093380T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98112775 1998-07-09
PCT/EP1999/004605 WO2000002579A2 (en) 1998-07-09 1999-07-02 Component b as angiogenic agent in combination with human growth factors

Publications (1)

Publication Number Publication Date
DK1093380T3 true DK1093380T3 (da) 2003-01-27

Family

ID=8232248

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99934563T DK1093380T3 (da) 1998-07-09 1999-07-02 Komponent B som angiogent middel i kombination med humane vækstfaktorer

Country Status (12)

Country Link
US (2) US6855684B2 (da)
EP (1) EP1093380B1 (da)
JP (1) JP2002520292A (da)
AT (1) ATE224200T1 (da)
AU (1) AU765600B2 (da)
CA (1) CA2336773C (da)
DE (1) DE69903037T2 (da)
DK (1) DK1093380T3 (da)
ES (1) ES2184480T3 (da)
IL (2) IL140778A0 (da)
PT (1) PT1093380E (da)
WO (1) WO2000002579A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002520292A (ja) * 1998-07-09 2002-07-09 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ ヒト成長因子と組み合わせた血管形成剤としてのコンパウンドｂの使用
AU2001291019A1 (en) 2000-09-15 2002-03-26 Genvec, Inc. Method of modulating neovascularization
ES2359408T3 (es) * 2003-04-16 2011-05-23 Merck Serono Sa Uso de slurp-1 para tratar enfermedades relacionadas con la disfunción de receptores de acetilcolina.
WO2006060803A2 (en) * 2004-12-03 2006-06-08 Polnox Corporation One pot process for making polymeric antioxidants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
ATE234110T1 (de) * 1996-04-24 2003-03-15 Applied Research Systems Komponente b als wundheilendes mittel
JP2002520292A (ja) * 1998-07-09 2002-07-09 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ ヒト成長因子と組み合わせた血管形成剤としてのコンパウンドｂの使用

Also Published As

Publication number Publication date
CA2336773A1 (en) 2000-01-20
US20010031733A1 (en) 2001-10-18
WO2000002579A2 (en) 2000-01-20
CA2336773C (en) 2009-12-15
AU765600B2 (en) 2003-09-25
WO2000002579A3 (en) 2000-02-24
ES2184480T3 (es) 2003-04-01
DE69903037D1 (de) 2002-10-24
EP1093380B1 (en) 2002-09-18
ATE224200T1 (de) 2002-10-15
PT1093380E (pt) 2003-01-31
JP2002520292A (ja) 2002-07-09
US7223732B2 (en) 2007-05-29
US20050153892A1 (en) 2005-07-14
EP1093380A2 (en) 2001-04-25
IL140778A (en) 2008-03-20
IL140778A0 (en) 2002-02-10
DE69903037T2 (de) 2003-06-05
US6855684B2 (en) 2005-02-15
AU5030699A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
DK1071417T3 (da) Anvendelse af cannabidiol som anti-inflammatorisk middel
TR200002759T2 (tr) Bacak uyuşması sendromunun tedavisinde kabergolin kullanımı.
DK1235571T3 (da) Anvendelse af melatonin til behandling af androgenetisk eller diffus alopecia af feminin type
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
SE9701162D0 (sv) New use II
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
FR2757520B1 (fr) Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
DE69932510D1 (de) Vaskularisierungsinhibitoren
PT1089704E (pt) Locao tricologica para aplicacao topica
ATE279910T1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
CO5001019A1 (es) Composicion emulsionable para la represion de insectos, que se deriva del tipo de fenilpirazoles sustituidos en posi- cion 1, y no favorecen la formacion de cristales
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
ES2044849T3 (es) Un procedimiento para preparar un glicosido de flavona.
DK261490D0 (da) New pharmaceutical compound
PT1112083E (pt) Uso de um factor angiogenico para o tratamento de angiopatias microvasculares
BRPI0209619B8 (pt) agente promotor de crescimento capilar
BR0114814A (pt) Composições compreendendo composto de modafinila e seu uso
EA199900450A1 (ru) Агент, индуцирующий апоптоз
DK1093380T3 (da) Komponent B som angiogent middel i kombination med humane vækstfaktorer
CY1104971T1 (el) Παρασκευασμα αποϊνιδοτιδιου και g-csf και η χρηση του για να κινητοποιει αιμοποιητικους προγονους
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
DK578887A (da) Antihypertensiva
ES2172095T3 (es) Utilizacion de sulfitos y metabisulfitos, para la fabricacion de composiciones cosmeticas o farmaceuticas, particularmente en dermatologia, con efecto inhibidor de la melanogenesis o con actividad despigmentante.